Zobrazeno 1 - 10
of 97
pro vyhledávání: '"G M, Hahn"'
Publikováno v:
Radiation research. 151(4)
It is widely accepted that moderate levels of nonionizing electric or magnetic fields, for example 50/60 Hz magnetic fields of about 1 mT, are not mutagenic. However, it is not known whether such fields can enhance the action of known mutagens. To ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ecea3d4deef5c82dd454f4be03c67a9
https://pubmed.ncbi.nlm.nih.gov/10190502
https://pubmed.ncbi.nlm.nih.gov/10190502
Publikováno v:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 9(4)
An enzyme-linked immunosorbent assay (ELISA) for measurement of levels of heat shock proteins 73 and 72 (HSP73/72) in cultured cells and tissues is described. The assay involves detection of HSP73/72 in cell homogenates in 96-well plates using a spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f94100e6ca29477b9cf3372b6add37c
https://pubmed.ncbi.nlm.nih.gov/8366304
https://pubmed.ncbi.nlm.nih.gov/8366304
Publikováno v:
Cancer research. 52(24)
Normal bone marrow progenitors and some leukemic cells develop only a limited amount of thermotolerance. Further, once developed, thermotolerance decays at a faster rate than that normally observed in cells of nonhemopoietic origin. Thermotolerance i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2dab30c3d718af12da6e0535d32f931
https://pubmed.ncbi.nlm.nih.gov/1458470
https://pubmed.ncbi.nlm.nih.gov/1458470
Publikováno v:
Radiation research. 131(2)
The mechanism whereby tumor necrosis factor (TNF) kills mammalian cells is not well understood, although oxidative damage has been suggested by several investigators. Further, it is not known why cells vary in their responsiveness to TNF. We show tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f795dbd1a5be3e01f863729ed67c1a31
https://pubmed.ncbi.nlm.nih.gov/1641471
https://pubmed.ncbi.nlm.nih.gov/1641471
Publikováno v:
Cancer research. 52(10)
Three murine lymphoma cell lines, CH1, a B-cell lymphoma, and VL3 and RDM4, both T-cell lymphomas, were tested for their ability to induce heat shock protein synthesis and thermotolerance after heat shock. All three lines could develop thermotoleranc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c7cbf19280995764b821d1200692a437
https://pubmed.ncbi.nlm.nih.gov/1581899
https://pubmed.ncbi.nlm.nih.gov/1581899
Autor:
G. M. Hahn
Publikováno v:
Interstitial Hyperthermia ISBN: 9783709191576
The purpose of this chapter is to survey the existing literature on effects of heat on cells and on animal tumors, specifically as these relate to clinical use of interstitial hyperthermia used in conjunction with brachytherapy. Biology remains biolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::728fd8a7374ffceb1d5e180636b2fac9
https://doi.org/10.1007/978-3-7091-9155-2_1
https://doi.org/10.1007/978-3-7091-9155-2_1
Publikováno v:
Cancer research. 51(24)
Leukemic cells appear to develop less thermotolerance and then to lose their thermotolerance more rapidly than do other tumor cell lines. The reason for this phenomenon is not known. After heat shock (or other environmental stresses), mammalian cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::659e399f8599ff7386d6d69268141d24
https://pubmed.ncbi.nlm.nih.gov/1742734
https://pubmed.ncbi.nlm.nih.gov/1742734
Publikováno v:
Cancer research. 51(21)
Lonidamine enhances the cytotoxicity in vitro of several conventional antitumor drugs as well as that of hyperthermia (HT). We have investigated the possibility that such enhancement can also be demonstrated in vivo against the RIF-1 tumor system. Tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::238479efa34e3753b1d0e70d7dabe138
https://pubmed.ncbi.nlm.nih.gov/1718588
https://pubmed.ncbi.nlm.nih.gov/1718588
Publikováno v:
Cancer research. 50(24)
Lonidamine is an agent that is reported to inhibit recovery from potentially lethal damage. By itself, it has only mild anticancer activity. We have examined the ability of lonidamine to enhance the cytotoxicity of several drugs against a mouse and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95e21bbe29724c5decbe9650c3d5febd
https://pubmed.ncbi.nlm.nih.gov/2253227
https://pubmed.ncbi.nlm.nih.gov/2253227